Found: 20
Select item for more details and to access through your institution.
Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 424, doi. 10.3390/jpm11050424
- By:
- Publication type:
- Article
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987639
- By:
- Publication type:
- Article
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987639
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e17, doi. 10.1016/j.cllc.2021.06.013
- By:
- Publication type:
- Article
Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 161, doi. 10.1016/j.cllc.2020.12.004
- By:
- Publication type:
- Article
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5326, doi. 10.3390/cancers15225326
- By:
- Publication type:
- Article
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 435, doi. 10.3390/cancers14020435
- By:
- Publication type:
- Article
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1300, doi. 10.3390/cancers13061300
- By:
- Publication type:
- Article
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 67, doi. 10.3390/cancers12010067
- By:
- Publication type:
- Article
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population‐based nationwide study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1661, doi. 10.1111/1759-7714.13456
- By:
- Publication type:
- Article
Role of anti-PD-1 antibody-Fc/FcR interaction on macrophages in inducing hyperprogressive disease in non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e372, doi. 10.1093/oncolo/oyad273
- By:
- Publication type:
- Article
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1078822
- By:
- Publication type:
- Article
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.902967
- By:
- Publication type:
- Article
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.857515
- By:
- Publication type:
- Article